Phenazone
Therapeutic Category:
Anti-Pyretic
Analgesic and antipyretic; inhibits prostaglandin synthesis by non-selectively inhibiting cyclooxygenase (COX)
Primary Use:
Fever and mild pain
Not spectrum-based; general anti-inflammatory and analgesic
Target Species:
Dogs, horses
Status:
Commercial
Monograph:
BP
Regulatory Status:
DMF
Disclaimer*
NGL FINE CHEM LIMITED is committed to protect the intellectual property (IP) generated in house and equally committed to respect the IP rights of all entities. Certain pipeline products may have valid patent(s) by other in India and/or in other jurisdictions. NGL offers such patented products for research and testing purpose only. The buyer will have the exclusive responsibility to respect the third party patent rights whether related to product or process.